Takeda Pharmaceutical Co Ltd Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2017 Mar2018 Mar2019 Mar2020 Mar2021 Mar2022 Mar2023 Mar2024 Mar2025
Operating Activities
Net Income 1.07B1.69B1.22B0.41B3.55B2.05B2.35B1.00B0.71B
Asset Writedowns and Impairment 0.47B0.12B0.09B0.94B0.24B0.49B0.48B1.04B0.70B
Cash from Operations 2.79B3.68B3.37B8.25B11.44B11.25B8.61B6.37B7.93B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 1.59B1.64B2.23B5.37B5.28B5.19B4.92B5.05B5.00B
Change in Working Capital
Change in Receivables -0.35B-0.01B-0.12B-0.32B-0.09B1.13B0.56B0.10B-0.39B
Change in Inventory 0.04B0.12B0.46B1.26B0.25B-0.41B-0.59B-0.80B-0.23B
Change in Account Payables 0.39B0.06B-0.15B-0.28B0.35B1.11B-0.63B-0.07B-0.05B
Change in Taxes 0.26B0.28B-0.07B-0.97B-0.09B0.64B0.43B-0.63B0.44B
Investing Activities
Capital Expenditures 0.57B0.60B0.70B1.17B1.05B1.10B1.04B1.22B1.32B
Sales of Property, Plant and Equipment 0.02B0.03B0.46B0.12B0.44B0.02B0.01B0.06B0.00B
Divestments 0.60B0.77B0.77B4.25B5.00B0.25B0.06B0.14B0.13B
Change in Acquisitions & Divestments -0.19B0.12B-0.07B-0.13B-0.10B-0.07B-0.02B-0.03B-0.01B
Cash from Investing Activities -6.06B-0.84B-25.59B2.69B3.71B-1.76B-4.49B-3.22B-2.41B
Financing Activities
Other financing activities -0.05B-0.04B0.18B-0.04B-0.00B-0.00B-0.07B-0.18B-0.11B
Cash from Financing Activities 2.68B-2.94B26.58B-9.25B-10.27B-9.53B-5.25B-2.46B-4.93B
Dividend Payments
Dividends Paid - Common 1.33B1.30B1.29B2.60B2.68B2.53B2.07B2.00B1.99B
Additional items
Exchange Rate Effect 0.05B0.04B-0.28B-0.20B0.12B0.26B0.17B0.18B-0.07B
Change in Cash -0.97B-0.38B3.96B-0.40B2.98B-1.29B-2.51B-0.71B-0.40B
Beginning Cash Balance 3.92B3.03B2.37B6.27B6.13B8.86B6.46B3.88B2.93B
Free Cash Flow 2.22B3.08B2.67B7.08B10.39B10.16B7.57B5.15B6.61B
Net Cash Flow -0.59B-0.11B4.37B1.69B4.88B-0.04B-1.13B0.69B0.58B